Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2020 08:00 ET | Source: BioSyent Inc.

BioSyent Releases Results for Fourth Quarter and Full Year 2019

MISSISSAUGA, Ontario, March 18, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and twelve months ended December...
March 11, 2020 08:00 ET | Source: BioSyent Inc.

BIOSYENT SCHEDULES Q4 AND FULL YEAR 2019 EARNINGS RELEASE FOR MARCH 18, 2020

MISSISSAUGA, Ontario, March 11, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and twelve months ended...
March 06, 2020 17:30 ET | Source: BioSyent Inc.

BioSyent Announces Adoption of Restricted Share Unit Plan

MISSISSAUGA, Ontario, March 06, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a Restricted Share Unit Plan...
December 11, 2019 08:00 ET | Source: BioSyent Inc.

BioSyent Announces Renewal of Normal Course Issuer Bid

MISSISSAUGA, Ontario, Dec. 11, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the...
November 25, 2019 17:00 ET | Source: BioSyent Inc.

BioSyent Signs Exclusive Agreement for Pain Management Products

MISSISSAUGA, Ontario, Nov. 25, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive License...
November 20, 2019 08:00 ET | Source: BioSyent Inc.

BioSyent Releases Results for Third Quarter and First Nine Months of 2019

MISSISSAUGA, Ontario, Nov. 20, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and nine months ended September...
November 12, 2019 08:00 ET | Source: BioSyent Inc.

BioSyent Schedules Q3 and YTD 2019 Earnings Release for November 20, 2019

MISSISSAUGA, Ontario, Nov. 12, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...
September 12, 2019 09:00 ET | Source: BioSyent Inc.

BioSyent Named to the Growth 500 Ranking of Canada's Fastest-Growing Companies for Seventh Consecutive Year

MISSISSAUGA, Ontario, Sept. 12, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been named to the 31st annual Growth 500 ranking of Canada’s...
August 23, 2019 08:00 ET | Source: BioSyent Inc.

BioSyent Releases Q2 and H1 2019 Results

MISSISSAUGA, Ontario, Aug. 23, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30,...
August 15, 2019 08:00 ET | Source: BioSyent Inc.

BioSyent Schedules Q2 and H1 2019 Earnings Release for August 23, 2019

MISSISSAUGA, Ontario, Aug. 15, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30,...